Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 39
N.J. Vioxx Judge Enters $17 Million in Judgments in Two Cases
Special Master Suggests Federal Privilege Law Govern MDL Discovery
Texas Judge Says Generic Allegations Don't Preclude Diversity Jurisdiction
Calif. Plaintiffs Seek to Certify Class of Vioxx Purchasers
Federal Rule Can't Supplant State's Statute of Limitations to Revive Claims
MDL Plaintiffs Say Incomplete Record Should Preclude Interlocutory Review
Research Watch, Arthritis Drugs, August 2007
N.J. Court Affirms Dismissal of U.K. Plaintiffs' Vioxx Claims
